The prognosis from a CPG3 cancer is considered intermediate and your risk of dying of prostate cancer is about the same as your risk of dying of other causes. This, however, depends on how old you are, your general state of health and your other medical conditions. There is also be a higher risk of the cancer spreading (metastasis) if left untreated. Treatment is therefore considered likely to be of benefit to you.
The National Institute for Health and Care Excellence currently recommends that men diagnosed with CPG3 cancer are offered treatment with the intention of cure.
Active surveillance, however, can still be considered if you are not keen on or are unable to proceed with immediate treatment. This however depends on how old you are, your general state of health and your other medical conditions. Other factors may also need to be considered such as the amount of cancer in the biopsies or if there are any unusual features from your investigations.
Based on the NICE recommendations you are likely to be offered:
Based on the NICE recommendations you may be asked to consider:
